Please provide your email address to receive an email when new articles are posted on . Atezolizumab after surgery and chemotherapy reduced risk for disease recurrence or death among patients with ...
The study from China sought to evaluate clinical factors associated with survival after recurrence following surgery in ICC. An 8-year study of patients who underwent hepatectomy for intrahepatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback